# A Model of Computer-assisted Prescription of Erythropoiesis-stimulating Agents (ESA) in Patients Under Hemodialysis

Study · id `cardio:ct-nct04185519` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04185519](<https://clinicaltrials.gov/study/NCT04185519>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04185519

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

## Technical summary

Registry record NCT04185519. Randomized; single masking; primary purpose other. Start 2019-07-24 (actual); primary completion 2020-07-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Not applicable
- Enrolled: 126 participants (enrolled count; ClinicalTrials.gov record NCT04185519, source copy `cardio:ctgov-nct04185519-2021-09-01`, retrieved 2026-10-26)
- Started: 2019-07-24 (actual) (ClinicalTrials.gov record NCT04185519, source copy `cardio:ctgov-nct04185519-2021-09-01`, retrieved 2026-10-26)
- Primary completion: 2020-07-30 (actual) (ClinicalTrials.gov record NCT04185519, source copy `cardio:ctgov-nct04185519-2021-09-01`, retrieved 2026-10-26)
- Completion: 2020-07-30 (actual) (ClinicalTrials.gov record NCT04185519, source copy `cardio:ctgov-nct04185519-2021-09-01`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT04185519, source copy `cardio:ctgov-nct04185519-2021-09-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04185519-2021-09-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Model of Computer-assisted Prescription of Erythropoiesis-stimulating Agents (ESA) in Patients Under Hemodialysis
- Condition: End Stage Renal Disease
- Intervention (Device): AI (model)
- Lead sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital (`cardio:org-kaohsiung-medical-university-chung-ho-memorial-hospital`)

## Provenance

Content hash: 74397e56920fe2421c2f8c95cc7cc3463dee17a625fc1f0c419b8c383ec20e6e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
